Skip to content
Screener

Bausch Health Companies BHC Intangibles (Net)

Intangibles (Net) at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$1.37B-12.3%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$48.23B
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$1.63M-33.4%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$26.48M-14.0%
TTR
Turn Therapeutics Inc.TTRX
$919.95K
PBH
Prestige Consumer HealthcarePBH
$408.03M+164%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.37B+11.7%
Enterprise value$21.83B-1.3%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
(in millions)March 31, 2026 / Gross Carrying AmountMarch 31, 2026 / Accumulated Amortizationand ImpairmentsMarch 31, 2026 / Net Carrying AmountDecember 31, 2025 / Gross Carrying AmountDecember 31, 2025 / Accumulated Amortizationand ImpairmentsDecember 31, 2025 / Net Carrying Amount
Product brands$22,475$(20,131)$2,344$22,534$(19,981)$2,553
Corporate brands1,001(807)1941,003(789)214
Product rights/patents3,268(3,251)173,271(3,253)18
Partner relationships, technology and other439(388)51445(385)60
Total finite-lived intangible assets27,183(24,577)2,60627,253(24,408)2,845
Acquired IPR&D100100100100
B&L Trademark1,6981,6981,6981,698
$28,981$(24,577)$4,404$29,051$(24,408)$4,643

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's intangibles (net)?
Bausch Health Companies (BHC) reported intangibles (net) of $2.61B in Q1 2026.
How has Bausch Health Companies's intangibles (net) changed year-over-year?
Bausch Health Companies's intangibles (net) decreased by 25.5% year-over-year, from $3.5B to $2.61B.
What is the long-term trend for Bausch Health Companies's intangibles (net)?
Over 5 years (2020 to 2025), Bausch Health Companies's intangibles (net) has grown at a -19.6% compound annual growth rate (CAGR), from $8.45B to $2.85B.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Ask your AI about Bausch Health Companies's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude